Significance of genetic polymorphism investigations in pregnancy complications

Archives of Perinatal Medicine

Volumn 19, Issue 1, 2013, Pages 7-11

  Seremak Mrozikiewicz, Agnieszka ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Gene polymorphisms; Genetic analysis; Pregnancy complications

Indexed keywords

EID: 84879224410     PISSN: 15050580     EISSN: 15084868     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Ward K. (2008) Genetic factors in common obstetric disorders.Clin. Obstet. Gynecol. 51: 74-83.
2. Varga E. (2007) Inherited thrombophilia: key points for genetic counseling. J. Genet. Couns. 16: 261-277.
3. Massart F., Marcucci G., Brandi M.L. (2008) Pharmacogenetics of bone treatments: the VDR and ERalpha genestory. Pharmacogenomics 9: 733-746.
4. Narod S.A. (2010) BRCA mutations in the management of breast cancer: the state of the art. Nat. Rev. Clin. Oncol.7: 702-707.
5. Roots I., Laschinski G., Arjomand-Nahad F. et al. (2007)Genotype and phenotype relationship in drug metabolism.Ernst. Schering. Res. Found. Workshop. 59: 81-100.
6. Bertina R.M., Koeleman B.P., Koster T. et al. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369: 64-67.
7. Poort S.R., Rosendaal F.R., Reitsma P.H. et al. (1996)A common genetic variation in the 3-prime-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88: 3698-3703.
8. Jivraj S., Makris M., Saravelos S. Et al. (2009) Pregnancy outcome in women with factor V Leiden and recurrent miscarriage. BJOG 116: 995-998.
9. Mohamed M.A., El Moaty M.A., El Kholy A.F et al. (2010) Thrombophilic gene mutations in women with repeated spontaneous miscarriage. Genet. Test. Mol. Biomarkers. 14: 593-597.
10. Lund M., Nielsen H.S., Hviid T.V., Steffensen R. et al. (2010) Hereditary thrombophilia and recurrent pregnancy loss: a retrospective cohort study of pregnancy outcome and obstetric complications. Hum. Reprod. 25: 2978-2984.
11. Kovac M., Mitic G., Mikovic Z. et al. (2010) Thrombophilia in women with pregnancy-associated complications: fetal loss and pregnancy-related venous thromboembolism. Gynecol. Obstet. Invest. 69: 233-238.
12. Kupferminc M.J. (2005). Management of thrombophilia in women with PVC. Thromb. Res. 115: 46-50.
13. Rey E., Kahn S.R., David M. et al. (2003) Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 361: 901-908.
14. Larciprete G., Rossi F., Deaibess T. et al. (2010) Double inherited thrombophilias and adverse pregnancy outcomes: fashion or science? J. Obstet. Gynaecol. Res. 36:996-1002.
15. Wiwanitkit V. (2005). Roles of methylenetetrahydrofolate reductase C677T polymorphism in repeated pregnancy loss. Clin. Appl. Thromb. Hemost. 11: 343-345.
16. Ren A., Wang H. (2006) Methylenetetrahydrofolate reductase C677T polymorphism and the risk of unexplained recurrent pregnancy loss: a meta-analysis. Fertil. Steril.86: 1716-1722.
17. Mtiraoui N., Zammiti W., Ghazouani L. et al. (2006) Methylenetetrahydrofolate reductase C677T and A1298C polymorphism and changes in homocysteine concentrations in women with idiopathic recurrent pregnancy losses.Reproduction 131: 395-401.
18. Seremak-Mrozikiewicz A., Drews K., Kurzawinska G. et al. (2009) The connection between Arg353Gln polymorphism of coagulation factor VII and recurrent miscarriages.Ginekol. Pol. 80: 8-13.
19. Williams P.J., Broughton Pipkin F. (2011) The genetics of pre-eclampsia and other hypertensive disorders of pregnancy.Best. Pract. Res. Clin. Obstet. Gynaecol. 25: 405-417.
20. Jebbink J., Wolters A., Fernando F. et al. (2012) Molecular genetics of preeclampsia and HELLP syndrome-a review.Biochim. Biophys. Acta 1822: 1960-1969.
21. Williams P.J., Morgan L. (2012) The role of genetics in pre-eclampsia and potential pharmacogenomic interventions.Pharmgenomics. Pers. Med. 5: 37-51.
22. Seremak-Mrozikiewicz A., Barlik M., Perlik M. et al. (2011) Genetic variability of endothelin-1 system in gestational hypertension and preeclampsia. Ginekol. Pol. 82:363-370.
23. Kosmas I.P., Tatsioni A., Ioannidis J.P. (2003) Association of Leiden mutation in factor V gene with hypertension in pregnancy and pre-eclampsia: a meta-analysis. J. Hypertens. 21: 1221-1228.
24. Nurk E., Tell G.S., Refsum H. et al. (2006) Factor V Leiden, pregnancy complications and adverse outcomes: the Hordaland Homocysteine Study. QJM 99: 289-298.
25. Dudding T., Heron J., Thakkinstian A. et al. (2008) Factor V Leiden is associated with pre-eclampsia but not with fetal growth restriction: a genetic association study and meta-analysis. J. Thromb. Haemost. 6: 1869-1875.
26. Rath W. (2011) Pre-eclampsia and inherited thrombophilia: a reappraisal. Semin. Thromb. Hemost. 37: 118-124.
27. Millis R.M. (2011) Epigenetics and hypertension. Curr.Hypertens. Rep. 13: 21-28.
28. Alfirevic A., Alfirevic Z., Pirmohamed M. (2010) Pharmacogenetics in reproductive and perinatal medicine. Pharmacogenomics 11: 65-79.
29. Fitzpatrick E., Göring H.H., Liu H. et al. (2004) Fine mapping and SNP analysis of positional candidates at the preeclampsia susceptibility locus (PREG1) on chromosome 2. Hum. Biol. 76: 849-862.
30. DeFranco E., Teramo K., Muglia L. (2007) Genetic influences on preterm birth. Semin. Reprod. Med. 25: 40-51.
31. Nesin M. (2007) Genetic basis of preterm birth. Front.Biosci. 12: 115-124.
32. Esplin M.S. (2006) Preterm birth: a review of genetic factors and future directions for genetic study. Obstet. Gynecol. Surv. 61: 800-806.
33. Macones G.A., Parry S., Elkousy M. et al. (2004) A polymorphism in the promoter region of TNF and bacterial vaginosis: preliminary evidence of gene-environment interaction in the etiology of spontaneous preterm birth. Am. J. Obstet. Gynecol. 190: 1504-1508.
34. Simhan H.N., Krohn M.A., Roberts J.M. et al. (2003) Interleukin-6 promoter -174 polymorphism and spontaneous preterm birth. Am. J. Obstet. Gynecol. 189: 915-918.
35. Łukaszewski T., Barlik M., Seremak-Mrozikiewicz A. et al.(2009) Polymorphism in the genes of Toll-like receptors type 2 and type 4 (TLR-2 and TLR-4) and the risk of premature rupture of the membranes-preliminary study. Ginekol.Pol. 80: 914-919.